Erythropoietin-induced Treatment Costs in Patients Suffering from Renal Anemia – A Comparison between Biosimilar and Originator Drugs

  • F. Hörbrand, D. Rottenkolber, J. Fischaleck, J. Hasford
  • Das Gesundheitswesen, February 2014, Thieme Publishing Group
  • DOI: 10.1055/s-0033-1361111

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1055/s-0033-1361111